GB0427380D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0427380D0
GB0427380D0 GBGB0427380.1A GB0427380A GB0427380D0 GB 0427380 D0 GB0427380 D0 GB 0427380D0 GB 0427380 A GB0427380 A GB 0427380A GB 0427380 D0 GB0427380 D0 GB 0427380D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0427380.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0427380.1A priority Critical patent/GB0427380D0/en
Publication of GB0427380D0 publication Critical patent/GB0427380D0/en
Priority to PCT/EP2005/013296 priority patent/WO2006063762A1/en
Priority to PE2005001441A priority patent/PE20060742A1/en
Priority to TW094143968A priority patent/TW200635910A/en
Priority to GT200500365A priority patent/GT200500365A/en
Priority to ARP050105249A priority patent/AR052161A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB0427380.1A 2004-12-14 2004-12-14 Organic compounds Ceased GB0427380D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0427380.1A GB0427380D0 (en) 2004-12-14 2004-12-14 Organic compounds
PCT/EP2005/013296 WO2006063762A1 (en) 2004-12-14 2005-12-12 Dipeptide nitriles
PE2005001441A PE20060742A1 (en) 2004-12-14 2005-12-13 CRYSTALLINE SALTS OF N- [CYANOMETHYL-CARBAMOIL) -CYCLOHEXIL] -4- (PROPYL-PIPERAZI-1-NIL) -BENZAMIDE
TW094143968A TW200635910A (en) 2004-12-14 2005-12-13 Dipeptide nitriles
GT200500365A GT200500365A (en) 2004-12-14 2005-12-13 BIPEPTIDE NITRILS
ARP050105249A AR052161A1 (en) 2004-12-14 2005-12-14 DERIVATIVES OF N- [1- (CYANOMETIL-CARBAMOIL) -CICLOHEXIL] -4- (4-PROPIL-PIPERAZIN-1-IL) -BENZAMIDA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0427380.1A GB0427380D0 (en) 2004-12-14 2004-12-14 Organic compounds

Publications (1)

Publication Number Publication Date
GB0427380D0 true GB0427380D0 (en) 2005-01-19

Family

ID=34090027

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0427380.1A Ceased GB0427380D0 (en) 2004-12-14 2004-12-14 Organic compounds

Country Status (6)

Country Link
AR (1) AR052161A1 (en)
GB (1) GB0427380D0 (en)
GT (1) GT200500365A (en)
PE (1) PE20060742A1 (en)
TW (1) TW200635910A (en)
WO (1) WO2006063762A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2117605B1 (en) * 2007-02-28 2012-09-26 Sanofi Imaging probes
EP2262783A2 (en) * 2008-02-21 2010-12-22 Sanofi-Aventis Covalently binding imaging probes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4450988B2 (en) * 1997-11-05 2010-04-14 ノバルティス アーゲー Dipeptide nitrile
GB0003111D0 (en) * 2000-02-10 2000-03-29 Novartis Ag Organic compounds
JP2006528151A (en) * 2003-07-21 2006-12-14 ノバルティス アクチエンゲゼルシャフト Combination of cathepsin K inhibitor and bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
WO2005049028A1 (en) * 2003-11-19 2005-06-02 Novartis Ag Use of cathepsin k inhibitors in severe bone loss diseases

Also Published As

Publication number Publication date
AR052161A1 (en) 2007-03-07
TW200635910A (en) 2006-10-16
GT200500365A (en) 2006-07-17
WO2006063762A1 (en) 2006-06-22
PE20060742A1 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
GB0409921D0 (en) Organic compounds
GB0403038D0 (en) Organic compounds
GB0407723D0 (en) Organic compounds
GB0401334D0 (en) Organic compounds
GB0405289D0 (en) Organic compounds
GB0402797D0 (en) Organic compounds
GB0404434D0 (en) Organic compounds
GB0408078D0 (en) Organic compounds
GB0400781D0 (en) Organic compounds
GB0406515D0 (en) Organic compounds
GB0403115D0 (en) Organic compounds
GB0403254D0 (en) Organic compounds
GB0405723D0 (en) Organic compounds
GB0409236D0 (en) Organic compounds
GB0427380D0 (en) Organic compounds
GB0406240D0 (en) Organic compounds
GB0407468D0 (en) Organic compounds
GB0407607D0 (en) Organic compounds
GB0405898D0 (en) Organic compounds
GB0405034D0 (en) Organic compounds
GB0405900D0 (en) Organic compounds
GB0406738D0 (en) Organic compounds
GB0403964D0 (en) Organic compounds
GB0410261D0 (en) Organic compounds
GB0400177D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)